Studies

Maumee Pediatric Associates ShotBlocker Patient Study

By Dr. James Huttner, MD, Ph.D. Maumee Pediatric Associates. Study Period: April- July 2002. In 2002, Maumee Pediatric Associates, the pediatric practice of Dr. James Huttner inventor of ShotBlocker®, conducted a study on parent’s assessment of the ShotBlocker. Parents were asked to complete a short survey immediately after their child had been given an injection with the aid of ShotBlocker. Eighty two surveys were completed… (Read More)

Assessment of Discomfort with Usual Immunization Practice Compared to the Use of Usual Practice and ShotBlocker

By Todd Gundrum,. Pharm.D., Christopher Sherman, M.D. and Scott Ruhlman. Family Physicians Association of Flower Hospital. Study Period: October 2000- February 2001. The pain elicited by administering immunizations can be a significant cause of anxiety and fear in many patients. This apprehension can be one reason a person may decline immunizations and can impair the clinician’s ability to perform an examination. This project uses a… (Read More)

Efficacy of ShotBlocker (Ma. Abigail D. Guevarra, MD)

Ma. Abigail D. Guevarra, MD. Department of Pediatrics, St. Luke’s Medical Center, Quezon City, Philippines. 2003. Fear of getting a shot is a major concern that must be addressed in children to encourage clinic visits and promote immunization. OBJECTIVES: This study aims to determine the effectiveness of ShotBlocker™ in reducing pain associated with intramuscular injection in preschool children. STUDY DESIGN: Randomized controlled trial. SETTING: Dalandanan Elementary School, Dalandanan, Valenzuela City.… (Read More)

Efficacy of ShotBlocker (American Journal of Emergency Medicine)

Lisa A. Drago DOa, Sabina B. Singh MDa,b, April Douglass-Bright MDc, Maame Yaa Yiadom MPHd, Brigitte M. Baumann MD, MSCEa American Journal of Emergency Medicine (2009) 27, 536–543. Objective: The aim of the study was to determine the efficacy of ShotBlocker™ (Bionix, Toledo, Ohio) in reducing pediatric pain with intramuscular (IM) injections. Methods: A prospective randomized controlled trial was conducted in children aged 2 months to… (Read More)

Aural Irrigation Using the OtoClear® Safe Irrigation System in Children

Ellen M. Mandel*, Joseph E. Dohar, Margaretha L. Casselbrant. International Journal of Pediatric Otorhinolaryngology (2004) 68, 1295—1299. Objective: To evaluate the safety and efficacy of the OtoClear® Safe Irrigation System for removing cerumen from the external auditory canal in children. Methods: Eligible subjects were 6 months—17 years of age with cerumen obstructing 50% of the tympanic membrane (TM) from view (by otoscopy). Pneumatic otoscopy, tympanometry, and audiometry were… (Read More)

SafeStraw Case Study

By: Chris Bolinger. University Medical Center Lubbock, TX 79415. November 2014. A 58 y.o. Hispanic male admitted to the hospital for hepatic encephalopathy after being found minimally responsive in his vehicle. Co-morbidities include: alcoholic liver cirrhosis, elevated LFTs, erosive esophagitis, hypertension, seizure due to alcohol withdrawal, and Wernicke’s encephalopathy. Chest X-ray on admission revealed possible pneumonia. Pt was oriented to person, but not place and time. Patient exhibited difficulty… (Read More)